Early uptake of doxycycline prophylaxis among MSM in Rome: Insights from a reference STI clinic
International Journal of STD & AIDS · 2026
DOI: 10.1177/09564624251375877 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2026. Verfasst von Maria Gabriella Donà und 7 weiteren Autor:innen. Beteiligte Einrichtung: STI/HIV Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Doxycycline, Homosexuality, Male, Anti-Bacterial Agents, Sexually Transmitted Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prompt doxycycline use (200 mg taken 24–72 hours after sexual activity, i.e., post-exposure prophylaxis, Doxy-PEP), effectively reduces chlamydia and syphilis acquisition in men who have sex with men (MSM) and individuals experiencing recurrent STIs. Considering the IUSTI Europe position statement and recent guidelines from the CDC, this study investigated the use of doxycycline to prevent STIs among MSM attendees of an STI/HIV center in Rome, Italy.
Methods
From June 2024 to February 2025, an anonymous self-administered questionnaire was used to collect data on sexual behaviors, HIV status, HIV pre-exposure prophylaxis (PrEP), STI history, recreational substances, and doxycycline PrEP/PEP use. Logistic regression analyzed associations between Doxy-PEP/PrEP use and behavioral/clinical factors.
Results
Two hundred and ninety MSM were enrolled. Among them, 9.3% reported using Doxy-PEP/PrEP, with nearly half accessing it without medical supervision. Multivariable analysis showed significant associations between doxycycline use and having ≥20 sexual partners, erectile drug use, and condomless anal sex.
Conclusions
While doxycycline remains an uncommon choice for STI prevention among our attendees, its usage is linked to individuals engaging in sex with multiple partners. These findings highlight the urgency of national guidelines to address informal prophylactic antibiotic use and ensure supervised STI prevention strategies among individuals at elevated risk for bacterial STIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- STI/HIV Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
ORCID-Profile: Eugenia Giuliani
Zitieren
APA
Donà, M. G., Zaccarelli, M., Giuliani, M., Stingone, C., Gianserra, L., Di Tullio, F., Giuliani, E., & Latini, A. (2026). Early uptake of doxycycline prophylaxis among MSM in Rome: Insights from a reference STI clinic. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251375877
Vancouver
Donà MG, Zaccarelli M, Giuliani M, Stingone C, Gianserra L, Di Tullio F, et al. Early uptake of doxycycline prophylaxis among MSM in Rome: Insights from a reference STI clinic. International Journal of STD & AIDS. 2026. doi:10.1177/09564624251375877
BibTeX
@article{Don2026,
author = {Donà, Maria Gabriella and Zaccarelli, Mauro and Giuliani, Massimo and Stingone, Christof and Gianserra, Laura and Di Tullio, Francesca and Giuliani, Eugenia and Latini, Alessandra},
title = {Early uptake of doxycycline prophylaxis among MSM in Rome: Insights from a reference STI clinic},
journal = {International Journal of STD & AIDS},
year = {2026},
doi = {10.1177/09564624251375877}
}
EUVIMED